Patent · US Expired

Use of insulin and IGF-I

US5994303A · kind A · utility

6Cited by

4References

20Claims

0Family size

Assignee

Chiron Corporation · US

Inventors

Vibeke Arrhenius-Nyberg · Järfälla, SE
Kjell Malmlof · Solna, SE
Anna Skottner · Ekerö, SE

Key dates

Filing date	Jan 5, 1998
Grant date	Nov 30, 1999
Priority date	—
Expiry date	Jan 5, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A combination of insulin and an insulin-like growth factor I (IGF-I) as used in the manufacture of a medicament for counteracting a decrease in nitrogen balance and for counteracting a decrease in protein synthesis. The medicament can be used for the treatment of catabolism which is a protein catabolism due to glucocorticoid excess.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.